Scopulariopsis brevicaulis as the cause of dermatomycosis

Acta Dermatovenerologica Croatica

Volumn 18, Issue 1, 2010, Pages 8-13

  Petanović, Mirna ^a   Paradžik, Maja Tomić ^a   Krištof, Željka ^a   Cvitković, Ante ^a   Topolovac, Zdenka ^b  

^a Public Health Institute of the Brod Posavina County   (Croatia)

^b DR JOSIP BEN EVI GENERAL HOSPITAL   (Croatia)

Author keywords

Dermatomycosis; Onychomycosis; Scopulariopsis brevicaulis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOMYCOSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; FUNGAL COLONIZATION; FUNGAL DETECTION; FUNGUS GROWTH; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; FUNGUS TRANSMISSION; HUMAN; INJURY; LEG BLOOD FLOW; MALE; METABOLIC DISORDER; NONHUMAN; PSORIASIS; RESIDENTIAL AREA; RISK FACTOR; RURAL AREA; SCHOOL CHILD; SCOPULARIOPSIS BREVICAULIS; SEBORRHEA; URBAN AREA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASCOMYCOTA; CHILD; DERMATOMYCOSES; DRUG RESISTANCE, FUNGAL; FEMALE; HUMANS; MALE; MIDDLE AGED; ONYCHOMYCOSIS; PREVALENCE; RETROSPECTIVE STUDIES; RURAL POPULATION;

EID: 77950573626     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Mlinarić Missoni E, Važić Babić V. Opća medicinska mikologija. In: Kalenić S, Mlinarić Missoni E, eds. Medicinska bakteriologija i mikologija. Zagreb: Prehrambeno tehnološki inženjering; 1995. pp. 430-431, 464, 475.
2. Andreoni S, Farina C, Lombardi G. Medical mycology atlas. Gilead Systems, CD ROM 2007.
3. Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago MJ, Monzon A, Rodriguez-Tudela JL. Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents. Antimicrob Agents Antimicrob Agents Chemother 2003;47:2339-41.
4. nd ed. Wu{double acute}rtzburg: CBS; 2004.
5. th ed. Washington, DC: ASM; 2002.
6. Wagner D, Sander A, Bertz H, Finke J, Kern WV. Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis. Infection 2005;33:397-400.
7. Ng KP, Soo-Hoo TS, Na SL, Gan GG, Sangkar JV, Teh AK. Scopulariopsis brevicaulis infection in a patient with acute myeloid leukemia. Med J Malaysia 2003;58:608-12.
8. Malecha MA. Fungal keratitis caused by Scopulariopsis brevicaulis treated successfully with natamycin. Cornea 2004;23:201-3.
9. Keram A, Hery G, Eveillard JR, Leroy JP, Leflohic AM, Sassolas B, et al. Subcutaneous mycosis due to Scopulariopsis brevicaulis in an aplasic patient. Ann Dermatol Venerol 2003;130:783-6.
10. Bonifaz A, Cruz-Aquilar P, Ponce RM. Onychomycosis by molds. Report of 78 cases. Eur J Dermatol 2007;17:70-2.
11. Seeliger HPR, Heymer T. Diagnostik pathogener Pilze des Menschen und seiner Umwelt: Lehrbuch u. Atlas. Stuttgart, New York: Thieme; 1981. pp.230-232, 301.
12. Boukachabine K, Agoumi A. Onychomycosis in Morocco: experience of the Parasitology and Medical Mycology Laboratory from Rabat Children Hospital (1982-2003). Ann Biol Clin 2005;63:639-42.
13. Romano C, Gianni C, Difonzo EM. Retrospective study of onychomycosis in Italy: 1985-2000. Mycoses 2005;48:42-4.
14. Romano C, Papini M, Ghilardi A, Gianni C. Onychomycosis in children: a survey of 46 cases. Mycoses 2005;48:430-7.
15. Svejgaard EL, Nilson J. Onychomycosis in Denmark: prevalence of fungal nail infection in general practice. Mycoses 2004;47:131-5.
16. Kardjeva V, Summerbell R, Kantardjiev T, Devliotou-Panagiotidou D, Sotiriou E, Gräser Y. Forty-eight-hour diagnosis of onychomycosis with subtyping of onychomycosis with subtyping of Trichophyton rubrum strains. J Clin Microbiol 2006;44:1419-27.
17. Narita Y, Takiuchi I. A case of onychomycosis induced by Scopulariopsis brevicaulis. Nippon Ishinkin Gakkai Zasshi 2006;47:99-102.
18. Gottmann-Bonvallot S. Clinical types of onychomycosis. Ann Dermatol Venerol 2003;130:1237-43.
19. Vesper SJ, McKinstry C, Yang C, Haugland RA, Kercsmar CM, Yike I, et al. Specific molds associated with asthma in water-damaged homes. J Occup Environ Med 2006;48:852-8.
20. Cuenca-Estrella M, Gomez-Lopez A, Buitrago MJ, Mellado E, Garcia-Effron G, RodriguezTudela JL. In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis. Antimicrob Agents Chemother 2006;50:2248-50.
21. Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago MJ, Monzon A, Rodriguez-Tudela JL. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother 2006;50:917-21.
22. Carrillo-Muňoz AJ, Giusiano G, Guarro J, Quindos G, Guardia C, Del Valle O, et al. In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis. Int J Antimicrob Agents 2007;30:157-61.
23. Carrillo-Muňoz AJ, Cárdenes CD, Carrillo-Orive B, Rodríguez V, Del Valle O, Casals JB, et al. In vitro antifungal activity of voriconazole against dermatophytes and superficial isolates of Scopulariopsis brevicaulis. Rev Iberoam Micol 2005;22:110-3.
24. Tosti A, Piraccini BM, Lorenzi S, Iorizzo M. Treatment of nondermatophyte mold and Candida onychomycosis. Dermatol Clin 2003;21: 491-7.